Sun Pharmaceutical Industries Ltd. — Capital/Financing Update 2018

Dec 3, 2018

Sun Pharmaceutical Industries Ltd. Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E) Mumbai – 400 063. Maharashtra, INDIA Tel : (91-22) 4324 4324 Fax : (91-22) 4324 4343 www.sunpharma.com CIN: L24230GJ1993PLC019050

==> picture [68 x 71] intentionally omitted <==

December 01, 2018

National Stock Exchange of India Ltd , BSE Ltd , Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. Scrip Name: SUNPHARMA Scrip Code:524715

Dear Sirs,

Sub: Approval of Scheme of Arrangement among Sun Pharma Global FZEand Sun Pharmaceutical Industries Limited and their respective members and creditors

This is to inform you that Scheme of Arrangement among Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (“the Company”) and their respective members and creditors for demerger of the Specified Undertaking (as defined in the Scheme of Arrangement) of Sun Pharma Global FZE into the Company, is effective from December 01, 2018 as the Company has filed the National Company Law Tribunal order along with Scheme of Arrangement in E-form INC-28 with Registrar of Companies, Gujarat today i.e. on December 01, 2018. The appointed date for the said Scheme of Arrangement is April 01, 2017.

This is for your information and record.

Thanking you,

Yours faithfully,

For Sun Pharmaceutical Industries Limited

==> picture [82 x 28] intentionally omitted <==

Ashok I Bhuta Sr. GM – Secretarial & Compliance Officer

Registered Office : SPARC, Tandalja, Vadodara – 390 012. India